| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8944403 | Journal of Cardiology | 2018 | 8 Pages |
Abstract
In conclusion, standard-dose NOAC showed lower all-cause mortality than warfarin in OAC-naïve patients with AF, and low-dose NOAC was better than warfarin among the patients with prior-stroke history in terms of all-cause mortality.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
In-Soo MD, Hyun-Jung MPH, PhD, Tae-Hoon MD, Jae-Sun MD, PhD, Boyoung MD, PhD, Moon-Hyoung MD, PhD, Hui-Nam MD, PhD,